ADRIAN MCLEMORE: Open Payments
NPI 1902257124 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61 in 3 payments from 3 companies in 2025. Trend: 2023 $130 · 2024 $191 · 2025 $61
Food & beverage: $61
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: REXULTI, FARXIGA, SHINGRIX.
Industry payments across MS — which companies pay providers there.
